Back to search

Article

Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring <i>STAG2</i> mutations

2022-02-20

Abstract excerpt

Targeted therapies exploiting selective vulnerabilities of malignant cells are highly desired for clinical applications. The cohesin protein complex comprises of RAD21, SMC3, SMC1A as well as a fourth subunit that consists of either STAG1 or STAG2 and is essential for proper chromosomal segregation during mitosis. STAG2 loss-of-function mutations are recurrent driver events in acute myeloid leukemia (AML) and app...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4ba44b04-efc1-56e9-8f8e-f21f420dfd62
DOI
10.1101/2022.02.18.479480
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring <i>STAG2</i> mutationsDOI 10.1101/2022.02.18.479480
Select a neighboring publication to make it the new centre.